Results for “”

Entry Author Date Location
NeoGenomics Nabs Human Longevity’s Oncology Division for $37M 01/13/20 National
Biogen Adds Another Neuro Drug to Pipeline in Deal With Pfizer 01/13/20 Boston
Incyte Commits $900M to MorphoSys for Rights to Lymphoma Drug 01/13/20 National
Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans 01/13/20 Boston
Roche Pays $40M to Use Amunix Pharma’s Half-Life Extension Tech 01/13/20 National
Allogene, SpringWorks to Test Drug Combo in Multiple Myeloma Trial 01/13/20 San Francisco
Neurocrine, in Second Epilepsy Deal, Pairs With Swiss Biotech Idorsia 01/11/20 San Diego
Eli Lilly Gets Skin in the Eczema Game With $1.1B Deal for Dermira 01/10/20 Indiana
Biotech Roundup: Drug Pricing Promises, Bone Disease Data, IPO Plans & More 01/10/20 National
Biogen Teams Up With Startup CAMP4 to Scout for New Neuro Drugs 01/10/20 Boston
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs 01/09/20 San Diego
Solid Bio Restructures to Get Halted Gene Therapy Study Back on Track 01/09/20 Boston
UK Startups Double in Number Backed By Larger Scale Investments: Report 01/09/20 National
Empirico Raises $17M, Inks 3-Year Antisense Collaboration with Ionis 01/09/20 San Diego
Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy 01/08/20 San Francisco
Mirati Adds Execs With Commercial Experience at Spark, Bristol-Myers 01/08/20 San Diego
Novo Holdings Repositions Antibiotics Funding Amid “Deteriorated” Market 01/07/20 National
Apellis Rare Blood Disease Drug Tops Alexion’s in Head-to-Head Test 01/07/20 Boston
Takeda to Fund AI Projects at MIT as Part of New 3-Year Collaboration 01/07/20 Boston
Celgene-Seeded PharmAkea Sells Last Fibrotic Drug Candidate to Galecto 01/07/20 San Diego
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic 01/07/20 Boston
BioIntervene Raises $30M to Move Nerve Pain Drug Into the Clinic 01/07/20 San Diego
Merck Ramps Up KRAS Chase Through Licensing Deal With Taiho, Astex 01/06/20 New York
China’s CF PharmTech Raises $90M to Advance Respiratory Drug Development 01/06/20 National
Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More 01/03/20 National
After Antitrust Challenges, Illumina and PacBio Throw in Towel on Merger 01/03/20 San Diego
No More Fish or Fruit: Intrexon Turns SynBio Focus to Human Health 01/02/20 National
Rexgenero CEO Talks Importance of “Dialogue” in Cell Therapy Conversations 01/02/20 National
Wave’s Huntington’s Drug Disappoints in Clinical Trial, Stock Sinks 01/02/20 Boulder/Denver
Investors Go With Gut Ahead of Microbiome Therapy Boom, Says Seventure 01/01/20 National
Page 2 of 1958 « previous page · next page »